Assessing drug safety: How can we do it better?

被引：0
|
作者：
Kenna, JG [1 ]
机构：
[1] AstraZeneca, Global Safety Assessment, Macclesfield, Cheshire, England
来源：
DRUG METABOLISM REVIEWS | 2005年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
11
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [1] How Can We Do Better?
    Brown, Philip R.
    ACCOUNTING HORIZONS, 2013, 27 (04) : 855 - 859
  • [2] Postmarketing surveillance for drug safety: Surely we can do better
    Griffin, MR
    Stein, CM
    Ray, WA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (06) : 491 - 494
  • [3] New tuberculosis drug development - How can we do better?
    O'Brien, RJ
    Vernon, AA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (06) : 1705 - 1707
  • [4] We Can Do Better: With Patient Safety
    Payne, Glenda M.
    NEPHROLOGY NURSING JOURNAL, 2012, 39 (02) : 97 - 97
  • [5] Fungal diagnosis: how do we do it and can we do better?
    Perfect, John R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 : 3 - 11
  • [6] Malaria: How Are We Doing and How Can We Do Better?
    Rosenthal, Philip J.
    John, Chandy C.
    Rabinovich, N. Regina
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 100 (02): : 239 - 241
  • [7] Increasing adverse drug reaction reporting-How can we do better?
    Shchory, Miri Potlog
    Goldstein, Lee H.
    Arcavi, Lidia
    Shihmanter, Renata
    Berkovitch, Matitiahu
    Levy, Amalia
    PLOS ONE, 2020, 15 (08):
  • [8] TERMINAL CARE - HOW CAN WE DO BETTER
    WILKES, E
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1986, 20 (03): : 216 - 218
  • [9] ALL in Adults: How Can We Do Better?
    Burmeister, Thomas
    ONCOLOGY-NEW YORK, 2012, 26 (09): : 864 - 865
  • [10] Oncology protocols: how can we do better?
    Kaste, Sue C.
    PEDIATRIC RADIOLOGY, 2011, 41 : S166 - S169
12345